Neonc Technologies (NASDAQ:NTHI) CEO Amir Heshmatpour Purchases 3,000 Shares

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 3,000 shares of Neonc Technologies stock in a transaction dated Monday, August 17th. The shares were acquired at an average cost of $4.37 per share, for a total transaction of $13,110.00. Following the transaction, the chief executive officer directly owned 3,087,000 shares of the company’s stock, valued at approximately $13,490,190. This represents a 0.10% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Neonc Technologies Trading Up 16.4%

Shares of NTHI stock traded up $0.69 during trading on Monday, reaching $4.91. The company’s stock had a trading volume of 378,880 shares, compared to its average volume of 92,168. Neonc Technologies Holdings, Inc. has a 1-year low of $3.01 and a 1-year high of $12.99. The stock’s 50-day moving average price is $4.11 and its 200 day moving average price is $6.08.

Neonc Technologies (NASDAQ:NTHI) last released its earnings results on Friday, August 14th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.46).

Analyst Ratings Changes

Several research firms recently commented on NTHI. Wall Street Zen cut Neonc Technologies from a “hold” rating to a “sell” rating in a research note on Saturday. BTIG Research reissued a “buy” rating and set a $15.00 price objective on shares of Neonc Technologies in a research report on Tuesday, May 26th. Weiss Ratings cut shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, June 24th. Alliance Global Partners assumed coverage on shares of Neonc Technologies in a research note on Tuesday, May 19th. They issued a “buy” rating and a $13.00 price target for the company. Finally, Maxim Group started coverage on shares of Neonc Technologies in a report on Monday, May 18th. They set a “buy” rating and a $20.00 price target for the company. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Neonc Technologies currently has a consensus rating of “Hold” and a consensus price target of $16.00.

Institutional Trading of Neonc Technologies

A number of institutional investors have recently bought and sold shares of NTHI. HighPoint Advisor Group LLC raised its position in shares of Neonc Technologies by 20.5% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,144,640 shares of the company’s stock worth $9,466,000 after acquiring an additional 194,408 shares in the last quarter. Bank of America Corp DE boosted its holdings in Neonc Technologies by 5.0% in the first quarter. Bank of America Corp DE now owns 235,396 shares of the company’s stock valued at $1,650,000 after purchasing an additional 11,108 shares in the last quarter. Westmount Partners LLC increased its stake in Neonc Technologies by 355.2% in the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock valued at $893,000 after purchasing an additional 153,858 shares during the last quarter. BlackRock Inc. purchased a new position in Neonc Technologies in the second quarter valued at approximately $815,000. Finally, Vanguard Group Inc. acquired a new stake in Neonc Technologies during the third quarter worth approximately $1,279,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.